文献速递中医妇科中药与中成药合理使用

中成药联合常规西药治疗子痫前期的系统评价与贝叶斯网络Meta分析

Efficacy of Chinese patent medicines combined with conventional western medicine in treatment of preeclampsia: A systematic review and Bayesian network meta-analysis.
PubMed 文献 · J Ethnopharmacol · 2025-08-11

结果显示所有中成药在降压、降低24小时尿蛋白及改善妊娠结局方面均有益处,其中羚羊角口服液、黄芪注射液与补肾健脾活血颗粒联合方案在降压和降尿蛋白上表现突出,复方丹参注射液对改善妊娠结局效果显著。结论认为中成药联合CTs较单用CTs可改善临床结局,但需高质量临床试验验证。

要点

  • 中成药联合常规西药治疗子痫前期在降压、降尿蛋白及改善妊娠结局方面均显示获益。
  • 羚羊角口服液、黄芪注射液与补肾健脾活血颗粒联合方案在降压和降尿蛋白方面表现突出。
  • 复方丹参注射液对改善妊娠结局(如提高新生儿出生体重、降低新生儿窒息等风险)效果显著。

核心结论

  • 中成药联合常规西药治疗子痫前期与改善临床结局相关,但需高质量临床试验验证。

研究设计与样本

  • 研究已在PROSPERO注册(注册号CRD42024602456)。

主要发现

  • 所有中成药在降低血压、降低24小时尿蛋白水平及改善妊娠结局方面均显示益处。
  • 羚羊角口服液、黄芪注射液与补肾健脾活血颗粒联合方案在降低血压和尿蛋白水平方面较单用常规西药尤为有效。
  • 复方丹参注射液在改善妊娠结局方面表现突出,包括提高新生儿出生体重及降低新生儿窒息、胎儿宫内窘迫、围产期死亡、胎盘早剥和产后出血风险。

临床怎么用

  • 临床可考虑在常规西药基础上联合中成药治疗子痫前期,以辅助降压、降低尿蛋白及改善妊娠结局。
  • 选择具体中成药时需结合患者临床特征及药物可及性,并关注证据质量。

局限性

  • 结论基于初步结果,需高质量、设计良好的临床试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Conventional Western treatments (CTs) for preeclampsia (PE) are often linked to serious side effects, such as higher rates of cesarean delivery and medically induced preterm birth. In contrast, recent clinical research has highlighted the potential of Chinese patent medicines (CPMs) as an effective alternative treatment. These studies show that CPMs may help lower blood pressure, reduce 24-h urinary protein levels, and improve pregnancy outcomes. AIM OF THE STUDY: This study evaluates the effectiveness of 11 CPMs used alongside CTs for PE. A network meta-analysis (NMA) was conducted to compare and rank their therapeutic benefits. MATERIALS AND METHODS: A comprehensive search was carried out across multiple databases up to December 2024 to identify studies assessing the effectiveness of CPMs for treating PE. Two independent reviewers screened the studies, extracted data, and evaluated the risk of bias. The NMA was conducted using a Bayesian approach, with statistical analyses performed in StataSE and RStudio. A network diagram, league tables, and SUCRA (surface under the cumulative ranking curve) plots were generated to compare and rank the treatments. This study is registered with PROSPERO (Registration number: CRD42024602456). RESULTS: A total of 61 studies involving 7044 patients with PE were included, examining the effects of 11 different CPMs. All CPMs showed benefits in lowering blood pressure, reducing 24-h urinary protein levels, and improving pregnancy outcomes. Among the treatments, the combination of Antelope Horn Oral Liquid, Astragalus Injection, and Bushen Jianpi Huoxue Granules was particularly effective in reducing blood pressure and urinary protein levels compared to CTs alone. Additionally, Compound Danshen Injection stood out for its superior impact on pregnancy outcomes, including increased neonatal birth weight and reduced risks of neonatal asphyxia, intrauterine fetal distress, perinatal mortality, placental abruption, and postpartum hemorrhage. CONCLUSION: Combining CPMs with CTs for PE was associated with improved clinical outcomes compared to using CTs alone. However, high-quality, well-designed clinical trials should validate these preliminary results.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Chen J, Gu H, Wu H, et al. Efficacy of Chinese patent medicines combined with conventional western medicine in treatment of preeclampsia: A systematic review and Bayesian network meta-analysis. J Ethnopharmacol. 2025. PMID: 40803613. doi:10.1016/j.jep.2025.120401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。